Overall Technical outlook

Price Summary

On 2025-05-29, Eris Lifesciences Limited's stock began at 1613.0, climbed to 1664.3, dropped to 1587.5, and had 0.17% to end at 1615.7, with a volume of 219394 shares.
Over the course of 52 weeks, the stock peaked at 1615.7 and hit a low of 910.45.
According to 10 analysts, the future price is anticipated to vary between 1350.0 and 1880.0, with an average expected price of around 1667.0.

Technicals


Aroon: The Aroon indicator continues to show a bullish trend, with Aroon Up remaining at the 100 level. This suggests strong upward momentum, but the trend should be examined further using other indicators to confirm its strength and potential for continuation for ERIS.
ERIS aroon ca4ca4
Aroon chart for Eris Lifesciences Limited


Bol. Bands: The price is above the upper Bollinger Band and has stayed there since its last surge. This situation suggests strong bullish momentum, possibly indicating that the asset is overbought. While traders might see this as a sign of ongoing strength, they should also be aware that extended periods above the band often lead to corrections or reversals, signaling a potential change in trend.
ERIS bbands ca4ca4
Bolinger Bands chart for Eris Lifesciences Limited


Parabolic SAR: The PSAR continues to indicate a bullish outlook, setting a crucial support level. This strong support could bolster the ongoing upward trend, suggesting that the market may remain in a positive trajectory. Investors may view this as a sign of sustained bullish momentum.
ERIS psar ca4ca4
Parabolic Stop and Reverse chart for Eris Lifesciences Limited


Stochastic: The stochastic indicator is in a bullish mode, with the K-line crossing above the D-line and the 80 level for ERIS. This alignment suggests strong upward momentum, indicating that the market may continue to trend higher. Investors could interpret this as a positive sign of sustained market growth.
ERIS stoch ca4ca4
Stochastic chart for Eris Lifesciences Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages points to a bearish trend for Eris Lifesciences Limited, but the wavering slopes of the 20 and 50 SMAs indicate that this momentum may be weakening. This loss of strength could be a sign that the market is approaching a turning point, with the possibility of a bullish reversal on the horizon. Investors should watch for signs of a trend change as the current downtrend starts to fade.
ERIS trippleSMA ca4ca4
Tripple SMA chart for Eris Lifesciences Limited


A company's technical data, including stock price and trading volume, can provide valuable insights when considered alongside its fundamentals. These include financial performance, market share, and growth strategy, as well as broader industry dynamics. Examining these factors helps investors or analysts make more informed decisions, as the company's fundamentals offer context for understanding how and why certain technical patterns may emerge in the market.